Body Contouring Devices Market Size, Share & Trends Analysis Report By Type, By Application (Nonsurgical Skin Resurfacing, Nonsurgical Skin Tightening, Cellulite Treatment, Liposuction), By Region, And Segment Forecasts, 2021 - 2028

Report Overview

The global body contouring devices market size was valued at USD 2.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 14.6% from 2021 to 2028. Body contouring devices can be invasive and non-invasive or minimally invasive, which aims to reshape an area of the body. This can be done surgically via liposuction or through less invasive methods like cryo lipolysis, injection lipolysis, radiofrequency lipolysis, and laser lipolysis. The main goal of body contouring procedures is to eliminate unwanted and achieve firmness in the treatment area.

However, the advent of the COVID-19 pandemic has hugely affected the overall aesthetic market. But many aesthetic professionals believe that the pandemic might propel the growth of the market for body contouring devices. According to the American Society of Plastic Surgeons, the pandemic led to an increase in the acceptance of cosmetic procedures. The association carried out a survey of more than 1,000 women stating that 11% of the women are now more inclined and interested in nonsurgical procedures than before the pandemic.

Rising cases of obesity across the globe due to unhealthy lifestyles are anticipated to drive the market for body contouring devices. Improved safety and efficacy of these techniques resulting in increased life expectancy are also expected to boost their demand. Initiatives, such as M&A, novel product launches and partnerships, undertaken by major companies for product research and distribution are expected to drive the market further in the coming years.

In North America, the noninvasive and minimally invasive devices segment is expected to witness a CAGR of 14.4% from 2021 to 2028. Noninvasive fat reduction or nonsurgical fat reduction includes minimally invasive treatments that break down stubborn subcutaneous fat pockets beneath the skin. Major factors driving market growth include rising demand for body contouring treatment, as it is noninvasive and requires no downtime after completion of the procedure. SculpSure, developed by Cynosure, Inc., is a non-invasive body contouring laser device that targets and destroys around 24% of unwanted fat cells in 25 minutes.

According to the WHO, obesity is a global epidemic that has tripled since 1975, and currently, about 30% of the world’s population is obese. A sedentary lifestyle is a major underlying cause of obesity, disease, and disability. Levels of physical inactivity are virtually high in all developed and developing countries. Increased Urbanization has contributed immensely towards the increase in sedentary lifestyle which in turn escalated the prevalence of obesity globally.

The advent of the COVID-19 pandemic had affected the overall aesthetic and beauty market. All invasive and noninvasive esthetic procedures were severely affected amid the pandemic; this includes the body contouring market. According to Bloomberg, procedures such as non-invasive fat reduction, injection lipolysis, invasive liposuction soft tissue fillers, facelifts, eye lifts, eyelid surgeries, laser skin resurfacing, rhinoplasty, and tummy tucks decreased by 20% in the first half of 2020.

Type Insights

The noninvasive and minimally invasive devices segment dominated the market for body contouring devices and held the maximum share of 76.7% in 2020. The segment is expected to maintain dominance during the forecast period. Entry of various products, investment by market players, and high demand for noninvasive and minimally invasive procedures due to safe and cost-effective nature are some of the factors for the dominance in the market.

Invasive body contouring procedure, Liposuction or lipolysis, has remained one of the most popular and in-demand plastic surgery procedures for body contouring and is particularly effective in removing fat in the legs, abdomen, back, arms, face, and neck. According to the American Society of Plastic Surgeons (ASPS), liposuction was the second-most carried out procedure in the U.S. after breast augmentation, with 270,670 procedural volume in 2019.

Liposuction is considered one of the most effective procedures for body fat removal, as it can remove up to 5 liters (11 pounds) of fat from this procedure. However, with the advent of non-invasive treatments that are cost-effective and deliver the same results, the demand for liposuction has witnessed a slight decline. According to Healthline, as the procedure requires surgical intervention, its cost might be more than other procedures and this might impede market growth.

Application Insights

The other application segment dominated the market for body contouring devices and held the largest revenue share of 34.0% in 2020. The segment is expected to grow at a fast rate during the forecast period. This can be attributed to minimally invasive and noninvasiveness of the procedures and low cost as compared to an invasive procedure.

The others segment includes injectable body contouring and gastric band. Injectable body contouring can be done by FDA-approved treatment injections called Kybella. This injection contains deoxycholic acid, which is naturally produced by the body to target fat cells. Kybella is injected every month for 3 to 6 sessions and after the treatment, the body breaks down and absorbs fat cells.

The non-surgical skin tightening segment is also expected to witness a CAGR of 15.0% during the forecast period. This is because, with age, collagen increases, and elastin production in the body decreases, giving the appearance of fine lines and dull and sagging skin. Noninvasive tightening devices like Thermage, Ulthera, and Pelleve assist in stimulating collagen and elastin production by inducing laser or ultrasound energy in the target area, which gradually improves the skin's texture and tone.

Regional Insights 

North America dominated the body contouring devices market and accounted for the largest revenue share of 35.8% in 2020. The segment is expected to showcase a significant CAGR during the forecast period. This is attributed to the rising geriatric population, strong medical infrastructure, well-established reimbursement policies, the existence of key market players, and advancement in aesthetic body contouring procedures. Moreover, Moreover, attributes like high acceptance and openness towards body contouring treatments, and soaring appearance-conscious customer pool is likely to propel the noninvasive body contouring market in the region of North America.

In APAC, the market for body contouring device is expected to witness the highest CAGR of 15.6% over the forecast period. Asian countries such as China, Japan, and India are emerging economies with well-developed healthcare infrastructure and facilities and are now more focused on leading on the basis of R&D activities. Asian countries have been a long renowned hub for aesthetic procedures. Numerous fat reduction procedures are carried out in countries like China, South Korea, and Japan per year, cost-effective and high-quality treatment, rising disposable income, and growing obese and geriatric population are driving the market for body contouring device in the APAC region.

Key Companies & Market Share Insights

A prominent number of these players are rapidly opting for geographical expansion, strategic collaborations, and partnerships through mergers and acquisitions in emerging and economically favorable regions. In June 2020, InMode Ltd. received Health Canada certification of Evolve Tone. This certification will make Evolve platform Canada's only, all-in-one hands-free device consisting of three unique body remodeling technologies - Tite, Trim, and Tone. Some of the prominent players in the body contouring devices market include:

• Cynosure, Inc.

• Alma Lasers

• Allergan Plc

• MerzPharmaGmbh

• Candela Medical Ltd.

• Solta Medical Bausch Health Companies, Inc.

• Lutronic Corporation

• InMode Ltd.

• Fotona

• Sofwave Medical Ltd.

• Sciton Inc.

• Lumenis

Body Contouring Devices Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global body contouring devices market report on the basis of type, application, and region:

• Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Noninvasive and Minimally Invasive Devices

  • Invasive Devices

• Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Nonsurgical skin Resurfacing

  • Nonsurgical skin tightening

  • Cellulite treatment

  • Liposuction

  • Others

• Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Spain

    • Italy

  • Asia Pacific

    • India

    • Japan

    • China

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE